Updates: bb2121 (myeloma CAR-T) and 1st line use of ivosidenib in AML
May 2, 2019
14:09
forum Ask episode
view_agenda Chapters
auto_awesome Transcript
info_circle Episode notes
Discussion of 2 important malignant hematology updates: the NEJM publication of the 1st published results of CAR-T therapy in multiple myeloma and the FDA-approval of ivosidenib in frail AML patients (with IDH1 mutations).
